Page 6 - Protein Expression News Today

Researchers evaluated the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on fetal brain health.

It's a good news, bad news story. Patients whose brain tumors have a mutated enzyme called IDH1 typically live longer than those without the mutation.

The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, according to a multi-institutional preclinical study led by Weill Cornell Medicine investigators.

Visiongain has published a new report entitled Protein Expression, Purification and Isolation Technology 2022-2032. It includes profiles of Protein...

/PRNewswire/ -- Forecasts by Technology (Protein Expression Technology (Cell-Free Expression, Bacterial Expression, Yeast Expression, Algal Expression, Insect...

Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells-;cells that control your heartbeat-;can "fight back" against therapies to biologically correct abnormal heartbeat rates.

Researchers identified a protein expression signature that can distinguish early diffuse alveolar damage (DAD) from late DAD in coronavirus disease 2019 (COVID-19) patients.

Researchers evaluated blood plasma proteins to identify new targets for COVID-19 treatment approaches and prevent complications associated with severe illness.

Researchers elucidated pan-sarbecovirus immune protection mechanisms by utilizing a Venezuelan equine encephalitis virus-vectored vaccine panel that covered bat strains to human strains.

Use of nanomedicines as adjuvants to systemic chemotherapy improving the survival of localized carcinomas, reducing the side effects of traditional drugs